{"id":"NCT01604278","sponsor":"Novartis Pharmaceuticals","briefTitle":"Efficacy, Safety and Tolerability of the Co-administration of NVA237 Plus Indacaterol Once Daily Versus Indacaterol Once Daily in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)","officialTitle":"A 12-week Multi-center, Randomized, Double-blind, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of the Co-administration of NVA237 + Indacaterol Once Daily vs. Indacaterol Once Daily in Patients With Moderate to Severe COPD","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-05","primaryCompletion":"2013-01","completion":"2013-01","firstPosted":"2012-05-23","resultsPosted":"2014-11-14","lastUpdate":"2014-11-14"},"enrollment":449,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Obstructive Pulmonary Disease (COPD)"],"interventions":[{"type":"DRUG","name":"NVA237 50 µg and indacaterol 150 µg","otherNames":["Glycopyrronium Bromide"]},{"type":"DRUG","name":"Placebo to NVA237 and indacaterol 150 µg","otherNames":[]}],"arms":[{"label":"NVA237 + indacaterol","type":"ACTIVE_COMPARATOR"},{"label":"Placebo to NVA237 + indacaterol","type":"PLACEBO_COMPARATOR"}],"summary":"This study assessed the efficacy, safety and tolerability of the co-administration of NVA237 plus indacaterol taken once daily versus indacaterol taken once daily in patients with moderate to severe Chronic Obstructive Pulmonary Disease.","primaryOutcome":{"measure":"Trough Forced Expiratory Volume at 1 Second (FEV1)","timeFrame":"12 weeks","effectByArm":[{"arm":"NVA237 + Indacaterol","deltaMin":1.499,"sd":0.0135},{"arm":"Placebo to NVA237 + Indacaterol","deltaMin":1.436,"sd":0.0136}],"pValues":[]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":6},"locations":{"siteCount":80,"countries":["Belgium","Bulgaria","Greece","Hungary","Ireland","Russia","Slovakia","Spain","Turkey (Türkiye)","United Kingdom"]},"refs":{"pmids":["24596459"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":226},"commonTop":["Chronic obstructive pulmonary disease"]}}